DSM Pharma Of U.S. Opens CMO Plant In Australia
This article was originally published in PharmAsia News
Executive Summary
U.S. drug maker DSM Pharmaceutical Products opened a biopharmaceutical contract-manufacturing plant in Australia in partnership with Biopharmaceuticals Australia.